PresolicitationActive75F40126Q00382
Preclinical Assessment of Naloxone Adequacy to Reverse Polysubstance Use-Induced Respiratory Depression — In Vivo Validation
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCSKey dates?
- Posted?
- Aug 26, 2026
- Response deadline?
- Sep 10, 2026, 7:00 PM UTC
- Archive date?
- Sep 25, 2026
- Archive type?
- auto15
Classification?
- Notice type?
- Presolicitation
- Base type?
- Presolicitation
- Set-aside?
- No Set aside used
- Set-aside code?
- NONE
- PSC?
- AN12
NAICS?
Issuing office?
- Department?
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF
- Sub-tier?
- FOOD AND DRUG ADMINISTRATION
- Office?
- FDA OFFICE OF ACQ GRANT SVCS
- Office code?
- 075.7524.75F401
- Organization type?
- OFFICE
- Office address?
- Rockville, MD, 20852, USA
Place of performance?
- Street?
- —
- Street 2?
- —
- City?
- —
- State?
- —
- Zip?
- —
- Country?
- UNITED STATES
Contacts?
- Kimberly Pennixprimary
- Ian Weisssecondary
Description
The full description is temporarily unavailable (SAM.gov rate limit) and will appear here shortly. View it now on SAM.gov ↗
Similar open contracts
Metadata?
- Notice ID?
- b587aac3a76a4528bd4298359acde021
- Full path?
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF.FOOD AND DRUG ADMINISTRATION.FDA OFFICE OF ACQ GRANT SVCS
- Office code?
- 075.7524.75F401
- Ingested?
- Aug 27, 2026
- Updated?
- Aug 27, 2026